Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Cipher Pharmaceuticals Schedules Q3 2021 Earnings Release and Conference Call

T.CPH

OAKVILLE, ON, Nov. 3, 2021 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) ("Cipher" or "the Company") today announced that it will release its Q3 2021 financial results on Thursday, November 11, 2021. The company will hold a conference call on Friday, November 12, 2021 at 8:30am ET to discuss the results.

CONFERENCE CALL DETAILS

DATE:

Friday, November 12, 2021

TIME:

8:30 a.m. EDT

DIAL-IN NUMBER:

(647) 792-1241 or (866) 248-8441

CONFERENCE ID:

9256970

REPLAY DIAL-IN:

(888) 203-1112 (playback 9256970 #)
Expires November 19, 2021

WEBCAST:

https://produceredition.webcasts.com/starthere.jsp?ei=1511252&tp_key=b261dfbc7e

About Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals (TSX: CPH) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and currently markets those products either directly in Canada or indirectly through partners in Canada, the U.S., and South America. For more information, visit www.cipherpharma.com.

SOURCE Cipher Pharmaceuticals Inc.

Cision View original content: http://www.newswire.ca/en/releases/archive/November2021/03/c4763.html